Sweden
· Delayed Price · Currency is SEK BioGaia AB Statistics
Total Valuation
BioGaia AB has a market cap or net worth of SEK 12.21 billion. The enterprise value is 11.20 billion.
| Market Cap | 12.21B |
| Enterprise Value | 11.20B |
Important Dates
The next estimated earnings date is Wednesday, February 12, 2025.
| Earnings Date | Feb 12, 2025 |
| Ex-Dividend Date | May 8, 2024 |
Share Statistics
BioGaia AB has 101.16 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Shares Outstanding | 101.16M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 1.83% |
| Owned by Institutions (%) | 37.70% |
| Float | 80.93M |
Valuation Ratios
The trailing PE ratio is 30.34 and the forward PE ratio is 34.88.
| PE Ratio | 30.34 |
| Forward PE | 34.88 |
| PS Ratio | 8.90 |
| PB Ratio | 7.74 |
| P/FCF Ratio | 33.89 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.20, with an EV/FCF ratio of 31.09.
| EV / Earnings | 27.89 |
| EV / Sales | 8.18 |
| EV / EBITDA | 22.20 |
| EV / EBIT | 23.32 |
| EV / FCF | 31.09 |
Financial Position
The company has a current ratio of 6.49
| Current Ratio | 6.49 |
| Quick Ratio | 4.58 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 28.96 |
Financial Efficiency
Return on equity (ROE) is 23.23% and return on invested capital (ROIC) is 17.36%.
| Return on Equity (ROE) | 23.23% |
| Return on Assets (ROA) | 14.80% |
| Return on Capital (ROIC) | 17.36% |
| Revenue Per Employee | 6.22M |
| Profits Per Employee | 1.83M |
| Employee Count | 210 |
| Asset Turnover | 0.67 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.15% in the last 52 weeks. The beta is 0.54, so BioGaia AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.54 |
| 52-Week Price Change | +19.15% |
| 50-Day Moving Average | 124.63 |
| 200-Day Moving Average | 118.64 |
| Relative Strength Index (RSI) | 43.20 |
| Average Volume (20 Days) | 414,940 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioGaia AB had revenue of SEK 1.37 billion and earned 401.72 million in profits. Earnings per share was 3.98.
| Revenue | 1.37B |
| Gross Profit | 1.01B |
| Operating Income | 480.38M |
| Pretax Income | 512.56M |
| Net Income | 401.72M |
| EBITDA | 493.83M |
| EBIT | 480.38M |
| Earnings Per Share (EPS) | 3.98 |
Balance Sheet
| Cash & Cash Equivalents | 1.01B |
| Total Debt | n/a |
| Net Cash | 1.01B |
| Net Cash Per Share | 9.96 |
| Equity (Book Value) | 1.58B |
| Book Value Per Share | 15.60 |
| Working Capital | 1.21B |
Cash Flow
In the last 12 months, operating cash flow was 394.03 million and capital expenditures -33.77 million, giving a free cash flow of 360.27 million.
| Operating Cash Flow | 394.03M |
| Capital Expenditures | -33.77M |
| Free Cash Flow | 360.27M |
| FCF Per Share | 3.56 |
Margins
Gross margin is 73.84%, with operating and profit margins of 35.08% and 29.34%.
| Gross Margin | 73.84% |
| Operating Margin | 35.08% |
| Pretax Margin | 37.43% |
| Profit Margin | 29.34% |
| EBITDA Margin | 36.06% |
| EBIT Margin | 35.08% |
| FCF Margin | 26.31% |
Dividends & Yields
This stock pays an annual dividend of 6.90, which amounts to a dividend yield of 5.72%.
| Dividend Per Share | 6.90 |
| Dividend Yield | 5.72% |
| Dividend Growth (YoY) | 137.93% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 137.00% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 5.71% |
| Earnings Yield | 3.30% |
| FCF Yield | 2.95% |
Stock Splits
The last stock split was on May 18, 2022. It was a forward split with a ratio of 5.
| Last Split Date | May 18, 2022 |
| Split Type | Forward |
| Split Ratio | 5 |